Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection

PLoS Pathogens(2023)10.1371/journal.ppat.1011772Source: DataRank Database

Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection is a research paper published in PLoS Pathogens (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (25 grants)Impact (FWCI 0.84)OA: goldTopics (49)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Simone I. Richardson ORCID,Roanne Keeton ORCID,Tandile Hermanus ORCID,Holly Spencer ORCID,Nelia P. Manamela ORCID

Live enrichment

PubMed:37943890 PMC:PMC10684107 OpenAlex:https://openalex.org/W4388521063

South African Medical Research Council

Grant: 96825 and SHIPNCD 76756

Department of Science and Innovation, South Africa

Grant: DST/CON 0250/2012

National Research Foundation South Africa

Grant: NRF 9834

Bill and Melinda Gates Foundation

Grant: INV-030570

Poliomyelitis Research Foundation

Grant: 21/65

Wellcome Centre for Infectious Diseases Research in Africa

Grant: 203135/Z/16/Z and 222574

European Union’s Horizon 2020 programme

Grant: TMA2017SF-1951-TB-SPEC

European Union’s Horizon 2020 programme

Grant: TMA2016SF-1535-CaTCH-22

Wellcome Trust

Grant: 226137/Z/22/ Z

National Institutes of Health

Grant: R21AI148027

Wellcome Trust

Grant: 203135/Z/16/Z

European & Developing Countries Clinical Trials Partnership (EDCTP)

Grant: TMA2016SF-1535

Wellcome Trust

Grant: 226137

Adaptive responses to SARS-CoV-2 variants in the context of hybrid immunity and immune impairment

NIAID NIH HHS

Grant: UM1 AI069469

Wellcome Trust

Grant: 222574

National COVID Testing Africa AAPs/Centre

European & Developing Countries Clinical Trials Partnership (EDCTP)

Grant: TMA2017SF-1951

National Institutes of Health

Grant: 1R21AI148027-01

Contribution of the CD153/CD30 axis to Mycobacterium tuberculosis control in humans

Wellcome Trust

Grant: 203135

Centre for Infectious Diseases Research in Africa (CIDRI-Africa)

Lily and Ernst Hausmann Trust

South African Medical Research Council

Wellcome Trust

Centre for the AIDS Programme of Research in South Africa

Medical Research Council

National Research Foundation South Africa

Wellcome Trust

FWCI

0.84

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011772&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011772&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1011772

journalhttps://doi.org/10.1371/journal.ppat.1011772

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37943890

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches0303 health sciences03 medical and health sciencesHumansAd26COVS1COVID-19SARS-CoV-2AntibodiesVaccinationAdaptive ImmunityAntibodies, ViralAntibodies, NeutralizingImmunity, HumoralSARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-2Ad26COVS1AntibodiesAntibodies, ViralHumansVaccinationAdaptive ImmunityImmunity, HumoralAntibodies, Neutralizing

Keywords

ImmunologyAntibodyVaccinationImmunityImmune systemBiologyAntigenMedicineAd26COVS1QH301-705.5SARS-CoV-2COVID-19RC581-607Adaptive ImmunityAntibodies, ViralAntibodies, NeutralizingArticleAntibodiesImmunity, HumoralHumansImmunologic diseases. AllergyBiology (General)Research Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being